Stephanie le
Dermatology · Sacramento, CANPI 1003345737
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Sanofi at 32.5% of the total. 2025 is the largest year on record at $6,701, 6.7 times the $993 reported in 2019.
Across 124 payments — averaging $127.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$5K
- AbbVie$3K
- E.r. Squibb & Sons, L.L.C.$3K
- Novartis$1K
- Regeneron Healthcare Solutions, Inc.$656
- Galderma Laboratories, L.p.$358
- plus $2K from 15 others
Across 102 payments — averaging $10,248 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$979K
- Novartis$64K
- Sanofi US Services Inc.$2K
What the payments were for
- Consulting fees$6,27340%
- Travel & lodging$1,3779%
- Food & beverage$7,87450%
- Education$2321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 11 | $5,113 |
| AbbVie(2 entities) | 27 | $3,103 |
| E.r. Squibb & Sons, L.L.C. | 18 | $3,018 |
| Novartis | 17 | $1,363 |
| Regeneron Healthcare Solutions, Inc. | 11 | $656 |
| Galderma Laboratories, L.p. | 4 | $358 |
| Janssen Scientific Affairs, LLC | 6 | $292 |
| Regeneron | 5 | $247 |
| Johnson & Johnson | 3 | $232 |
| Amgen | 3 | $208 |
| LEO Pharma Inc. | 2 | $188 |
| Sun Pharmaceutical Industries Inc. | 4 | $175 |
| Kyowa Kirin Co., Ltd | 2 | $169 |
| Merz North America, Inc. | 1 | $160 |
| Lilly USA, LLC | 1 | $125 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $109 |
| Pfizer | 1 | $73 |
| Argenx US, Inc. | 2 | $62 |
| Incyte Corporation | 1 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $43 |
| Kyowa Kirin, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,756 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $49,294 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sacramento
- Raja SivamaniSacramento$1.9M
- Emil TanghettiSacramento$800K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Tien NguyenFountain Valley$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.